(Q49135418)

18 February 2018

title

Genetic susceptibility and the occurrence of Parkinson's disease. (English)

1 reference

18 February 2018

author name string

Jenner P

series ordinal

1

1 reference

18 February 2018

publication date

1 December 1999

1 reference

18 February 2018

number of pages

5

1 reference

Parkinsonism and Related Disorders

inferred from page(s)

published in

1 reference

18 February 2018

volume

5

1 reference

18 February 2018

issue

4

1 reference

18 February 2018

page(s)

173-177

1 reference

18 February 2018

Genetics of Parkinson's disease

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900034-6

7 January 2021

A large kindred with autosomal dominant Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900034-6

7 January 2021

Genetic risk factors in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900034-6

7 January 2021

Mutation in the alpha-synuclein gene identified in families with Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900034-6

7 January 2021

Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900034-6

7 January 2021

The ubiquitin pathway in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900034-6

7 January 2021

A susceptibility locus for Parkinson's disease maps to chromosome 2p13.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900034-6

7 January 2021

The alpha-synuclein Ala53Thr mutation is not a common cause of familial Parkinson's disease: a study of 230 European cases. European Consortium on Genetic Susceptibility in Parkinson's Disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900034-6

7 January 2021

Mutation screening in exons 3 and 4 of alpha-synuclein in sporadic Parkinson's and sporadic and familial dementia with Lewy bodies cases

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900034-6

7 January 2021

Failure to find the alpha-synuclein gene missense mutation (G209A) in 100 patients with younger onset Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900034-6

7 January 2021

Mutation in the alpha-synuclein gene and sporadic Parkinson's disease, Alzheimer's disease, and dementia with lewy bodies

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900034-6

7 January 2021

Accumulation of alpha-synuclein/NACP is a cytopathological feature common to Lewy body disease and multiple system atrophy

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900034-6

7 January 2021

Filamentous alpha-synuclein inclusions link multiple system atrophy with Parkinson's disease and dementia with Lewy bodies

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900034-6

7 January 2021

Alpha synuclein is present in Lewy bodies in sporadic Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900034-6

7 January 2021

Alpha-synuclein and Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900034-6

7 January 2021

Parkinson's disease in twins

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900034-6

7 January 2021

Parkinson's disease in twins studied with 18F-dopa and positron emission tomography

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900034-6

7 January 2021

Parkinson disease in twins: an etiologic study

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900034-6

7 January 2021

Parkinson's disease. A genetic study

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900034-6

7 January 2021

Parkinson's disease: a test of the multifactorial etiologic hypothesis

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900034-6

7 January 2021

Parkinson's disease in twins

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900034-6

7 January 2021

Arteriosclerosis, heredity, and some previous infections in the etiology of Parkinson's disease. A case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900034-6

7 January 2021

A clinical genetic study of Parkinson's disease: evidence for dominant transmission

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900034-6

7 January 2021

Genetic linkage studies in autosomal dominant parkinsonism: evaluation of seven candidate genes

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900034-6

7 January 2021

Association of slow acetylator genotype for N-acetyltransferase 2 with familial Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900034-6

7 January 2021

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900034-6

1 reference

7 January 2021

Ecogenetics of Parkinson's disease: 4-hydroxylation of debrisoquine

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900034-6

7 January 2021

Debrisoquine metabolism in parkinsonian patients treated with antihistamine drugs

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900034-6

7 January 2021

MPTP, the neurotoxin inducing Parkinson's disease, is a potent competitive inhibitor of human and rat cytochrome P450 isozymes (P450bufI, P450db1) catalyzing debrisoquine 4-hydroxylation

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900034-6

7 January 2021

P450 enzymes and Parkinson's disease: the story so far.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900034-6

7 January 2021

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900034-6

1 reference

7 January 2021

CYP2D6 polymorphism and Parkinson's disease susceptibility

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900034-6

7 January 2021

Environmental factors in the etiology of Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900034-6

7 January 2021

Geography, drinking water chemistry, pesticides and herbicides and the etiology of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900034-6

7 January 2021

The risk of Parkinson's disease with exposure to pesticides, farming, well water, and rural living

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900034-6

7 January 2021

Nutritional and occupational factors influencing the risk of Parkinson's disease: a case-control study in southeastern Sweden

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900034-6

7 January 2021

Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900034-6

7 January 2021

A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900034-6

7 January 2021

Isoquinoline derivatives as endogenous neurotoxins in the aetiology of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900034-6

7 January 2021

n-Hexane-induced parkinsonism: pathogenetic hypotheses

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900034-6

7 January 2021

Neurological sequelae following carbon monoxide poisoning clinical course and outcome according to the clinical types and brain computed tomography scan findings

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900034-6

7 January 2021

Chronic manganese poisoning: a neuropathological study with determination of manganese distribution in the brain

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900034-6

7 January 2021

Etiology and pathogenesis of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900034-6

7 January 2021

Thioctic acid does not restore glutathione levels or protect against the potentiation of 6-hydroxydopamine toxicity induced by glutathione depletion in rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900034-6

7 January 2021

A data-driven approach to the study of heterogeneity in idiopathic Parkinson's disease: identification of three distinct subtypes

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900034-6

7 January 2021

10.1016/S1353-8020(99)00034-6

Identifiers

DOI

1 reference

18 February 2018

1 reference

18 February 2018